The Drug Enforcement Administration awarded a purchase order to VHG Labs Inc. for $87,343.00 on September 29, 2026, for synthesis of drug substances with an ultimate completion date of January 31, 2027. The order carries no set-aside designation and uses firm fixed price commercial items pricing under FAR Part 12.
Place of performance is Manchester, New Hampshire. The procurement was issued under an unrestricted, lowest-price technically-acceptable solicitation posted September 22, 2026, with quotations due September 25, 2026. The solicitation required pricing for 15 line items of specialized pharmaceutical substances including N-sec-butyl Butylone, Methiodone, Spirofluorphine, Methylorphine, Mexazolam, Cyclopropylflualprazolam, and nine additional related compounds, all for pharmacological testing. Award was made on an all-or-none basis to a single responsible offeror. NAICS code 325199 (All Other Basic Organic Chemical Manufacturing) and PSC 6810 (Chemicals) apply.